All News
Review of Bisphosphonates and Atypical femoral fractures
The Journal For Nurse Practitioners provides a succinct overview of atypical femoral fractures and bisphosphonates. These popular agents account for 14 million prescriptions annually in the United States.
Read Article
FDA Enforces New Drug Safety Labeling for Pregnant Women
The traditional FDA pregnancy risk categories (A, B, C, D, X) have been scrapped in favor of a new labeling mandate called the pregnancy and lactation labeling rule (PLLR). This change has been under consideration at the FDA for nearly 2 years and was brought about by the belief that the old
Read Article
Poisoning deaths involving opioid analgesics - NY State
Between 1999 and 2013 opiate-related deaths nearly quadrupled, with the death rate rising from 1.4 to 5.1 deaths per 100,000. These alarming statistics have lead to greater regulation and oversight to opiate use.
Read ArticlePregnant women getting better drug safety information
WASHINGTON - Pregnant women are about to get easier-to-understand information on how safe their medicine is for baby.
Read ArticleThe Safety of Restarting Infliximab After a Long Drug-Free Hiatus
Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological
Read Article
